Ventilation's Parameters Applied in Emergency Medicine. A Prospective Observational Study (PARAVENT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03351920 |
|
Recruitment Status :
Completed
First Posted : November 24, 2017
Last Update Posted : February 7, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
To prospectively assess the mechanical ventilation management when its provided by Emergency Physicians in French Hospital, and to assess complications and outcome of these patients.
The study could be measure the proportion of patients developing an Acute Respiratory Failure Distress after a take care of by French Emergency Departments.
| Condition or disease | Intervention/treatment |
|---|---|
| Mechanical Ventilation Acute Respiratory Distress Syndrome Protective Ventilation Survival | Other: mechanical ventilation |
| Study Type : | Observational |
| Actual Enrollment : | 229 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Ventilation's Parameters Applied in Emergency Medicine. Observational Study |
| Actual Study Start Date : | November 7, 2017 |
| Actual Primary Completion Date : | July 22, 2019 |
| Actual Study Completion Date : | August 8, 2019 |
- Other: mechanical ventilation
All patients who need an invasive or non invasive mechanical ventilation, initiated in Prehospital or IntraHospital Emergency Department by an emergency Physician
- Proportion of patients benefiting of a early low-volume ventilation initiated Emergency Department or Prehospital Care. [ Time Frame: Day 1 ]Early Low volume ventilation will be defined according to a VtE < 8mL/lg
- Proportion of patients benefiting of an early protective ventilation in Emergency Departments [ Time Frame: Day 1 ]
- Proportion of patients with acute respiratory distress syndrome according to the Berlin Definition during the first eight days of following. [ Time Frame: from Day 1 to Day 8 and Day 28 ]ARDS will be defined according to the Berlin definition.
- Proportion of survival from day 1 to Day 8, and to day 28 [ Time Frame: from Day 1 to Day 8 and Day 28 ]
- Indication to mechanical ventilation in Prehospital care and Emergency Departments [ Time Frame: Day 1 ]
- Mechanical Ventilation Duration in Emergency Departments [ Time Frame: Day 1 ]
- Mechanical ventilation settings in Emergency Departments [ Time Frame: Day 1 ]Recorded settings will be Ventilation mode, Tidal volume or Pressure Support Positive End Expiratory Pressure, Ventilation Rate, I : E ratio or Inspiratory Flow or Inspiratory Time.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age equal or over 18 years old
- Needing a invasive or noninvasive mechanical ventilation
- Mechanical ventilation initiated in Prehospital or IntraHospital Emergency Department by an Emergency Physician
Exclusion Criteria:
- Age under 18 years old
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03351920
| France | |
| Pierre-Arnaud Fort | |
| Agen, France, 47600 | |
| CHU de Bordeaux | |
| Bordeaux, France, 33000 | |
| Pierre-Marie Noël | |
| Brest, France, 29200 | |
| Paul Fievet | |
| La Rochelle, France, 17000 | |
| Thomas Lenormand | |
| Lorient, France, 56322 | |
| CH de Niort | |
| Niort, France, 79000 | |
| Marjanovic Nicolas | |
| Poitiers, France, 86000 | |
| Responsible Party: | Poitiers University Hospital |
| ClinicalTrials.gov Identifier: | NCT03351920 |
| Other Study ID Numbers: |
PARAVENT |
| First Posted: | November 24, 2017 Key Record Dates |
| Last Update Posted: | February 7, 2020 |
| Last Verified: | February 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Acute Lung Injury Emergencies Disease Attributes Pathologic Processes |
Lung Diseases Respiratory Tract Diseases Respiration Disorders Infant, Premature, Diseases Infant, Newborn, Diseases Lung Injury |

